The Preventive Effect of XSZII on Pregnancy-Induced Hypertension in Rats
Lei Wang
Abstract
Lei Wang
Abstract
Objective: To study the hypotensive and preventive effects of XSZⅡ on pregnancy-induced hypertension in rat model established by L-NAME. Methods: Pregnancy rats were assigned to 5 groups according to the sequence of pregnancy including normal pregnancy rats (A group, n = 6, PO distilled water 10 mL/kg from E10),hypertension control rats (B group, n = 10, PO distilled water 10 mL/kg from E10),Epsom salt control rats (C group,n = 8, ip Epsom salt 100 mg/kg from E14),XSZⅡ 42 g/kg group(D group,n = 10, PO XSZⅡ 42 g/kg from 10) and XSZⅡ 21 g/kg group(E group,n = 9, PO XSZⅡ 21 g/kg from E10). Pregnancy rats were injected 7 mg/kg L-NAME i.v. on the E14 once a day for 4 days except for rats of A group. The values of tail arterial blood pressure, urine protein, placental weight, fetal death rate and birth defects rate were measured in rats. Results: There were different significances in systolic blood pressure, diastolic blood pressure and mean arterial pressure between D and B group(P 0.01). The systolic blood pressure was significantly decreased in E group compared with that of B group (P 0.05). There was no significant improvement in urine protein in rats treated by XSZⅡ. The still birth rate was significant lower in E group than that of B group (P 0.01). The abnormal embryo rate was also significant lower in rats of E group than that of control group (P 0.01). Conclusion: For pregnancy-induced hypertension, XSZⅡ can effectively reduce the blood pressure and promote blood supply to the placenta and fetal rat development.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the hypotensive and preventive effects of XSZⅡ on pregnancy-induced hypertension in rat model established by L-NAME. Methods: Pregnancy rats were assigned to 5 groups according to the sequence of pregnancy including normal pregnancy rats (A group, n = 6, PO distilled water 10 mL/kg from E10),hypertension control rats (B group, n = 10, PO distilled water 10 mL/kg from E10),Epsom salt control rats (C group,n = 8, ip Epsom salt 100 mg/kg from E14),XSZⅡ 42 g/kg group(D group,n = 10, PO XSZⅡ 42 g/kg from 10) and XSZⅡ 21 g/kg group(E group,n = 9, PO XSZⅡ 21 g/kg from E10). Pregnancy rats were injected 7 mg/kg L-NAME i.v. on the E14 once a day for 4 days except for rats of A group. The values of tail arterial blood pressure, urine protein, placental weight, fetal death rate and birth defects rate were measured in rats. Results: There were different significances in systolic blood pressure, diastolic blood pressure and mean arterial pressure between D and B group(P 0.01). The systolic blood pressure was significantly decreased in E group compared with that of B group (P 0.05). There was no significant improvement in urine protein in rats treated by XSZⅡ. The still birth rate was significant lower in E group than that of B group (P 0.01). The abnormal embryo rate was also significant lower in rats of E group than that of control group (P 0.01). Conclusion: For pregnancy-induced hypertension, XSZⅡ can effectively reduce the blood pressure and promote blood supply to the placenta and fetal rat development.
Key concepts: Blood pressure, Pregnancy, Medicine, Distilled water, Urine, Internal medicine, Endocrinology, Group B